Takara Bio Inc. (4974.T)

JPY 1002.0

(-0.2%)

Total Liabilities Summary of Takara Bio Inc.

  • Takara Bio Inc.'s latest annual total liabilities in 2023 was 11.42 Billion JPY , down -31.82% from previous year.
  • Takara Bio Inc.'s latest quarterly total liabilities in 2024 Q1 was 10.23 Billion JPY , down -10.34% from previous quarter.
  • Takara Bio Inc. reported annual total liabilities of 16.75 Billion JPY in 2022, down -14.76% from previous year.
  • Takara Bio Inc. reported annual total liabilities of 19.65 Billion JPY in 2021, up 27.18% from previous year.
  • Takara Bio Inc. reported quarterly total liabilities of 12.45 Billion JPY for 2023 Q1, down -25.63% from previous quarter.
  • Takara Bio Inc. reported quarterly total liabilities of 11.42 Billion JPY for 2023 FY, down -31.82% from previous quarter.

Annual Total Liabilities Chart of Takara Bio Inc. (2023 - 2004)

Historical Annual Total Liabilities of Takara Bio Inc. (2023 - 2004)

Year Total Liabilities Total Liabilities Growth
2023 11.42 Billion JPY -31.82%
2022 16.75 Billion JPY -14.76%
2021 19.65 Billion JPY 27.18%
2020 15.45 Billion JPY 83.49%
2019 8.42 Billion JPY 21.2%
2018 6.94 Billion JPY 0.71%
2017 6.89 Billion JPY -3.66%
2016 7.16 Billion JPY 10.43%
2015 6.48 Billion JPY -4.44%
2014 6.78 Billion JPY 26.21%
2013 5.37 Billion JPY 3.66%
2012 5.18 Billion JPY -7.71%
2011 5.61 Billion JPY 12.97%
2010 4.97 Billion JPY -15.0%
2009 5.85 Billion JPY -1.94%
2008 5.96 Billion JPY -3.45%
2007 6.18 Billion JPY -10.78%
2006 6.92 Billion JPY -2.93%
2005 7.13 Billion JPY 30.09%
2004 5.48 Billion JPY 0.0%

Peer Total Liabilities Comparison of Takara Bio Inc.

Name Total Liabilities Total Liabilities Difference
KOHJIN BIO CO LTD 3.24 Billion JPY -251.717%
PRISM BioLab Co.,LTD 63.41 Million JPY -17909.494%
GNI Group Ltd. 26.34 Billion JPY 56.647%
Linical Co., Ltd. 10.3 Billion JPY -10.821%
Trans Genic Inc. 3.81 Billion JPY -199.538%
MEDINET Co., Ltd. 590.2 Million JPY -1834.924%
Soiken Holdings Inc. 697.02 Million JPY -1538.396%
Cytori Cell Research Institute, Inc. 3.02 Billion JPY -278.052%
AnGes, Inc. 2.78 Billion JPY -309.412%
OncoTherapy Science, Inc. 513.6 Million JPY -2123.49%
Nxera Pharma Co., Ltd. 90.38 Billion JPY 87.366%
Immuno-Biological Laboratories Co., Ltd. 353.27 Million JPY -3132.646%
NanoCarrier Co., Ltd. 1.64 Billion JPY -592.167%
Carna Biosciences, Inc. 472.35 Million JPY -2317.673%
CanBas Co., Ltd. 91.98 Million JPY -12314.663%
D. Western Therapeutics Institute, Inc. 1.09 Billion JPY -944.252%
RaQualia Pharma Inc. 809.83 Million JPY -1310.173%
Chiome Bioscience Inc. 593.73 Million JPY -1823.43%
Kidswell Bio Corporation 4.25 Billion JPY -168.448%
PeptiDream Inc. 29.11 Billion JPY 60.775%
Oncolys BioPharma Inc. 566.5 Million JPY -1915.887%
Ribomic Inc. 155.8 Million JPY -7229.487%
SanBio Company Limited 2.25 Billion JPY -406.454%
Healios K.K. 11.28 Billion JPY -1.187%
BrightPath Biotherapeutics Co., Ltd. 251.26 Million JPY -4444.93%
Kubota Pharmaceutical Holdings Co., Ltd. 369 Million JPY -2994.851%
Delta-Fly Pharma, Inc. 241.49 Million JPY -4628.837%
StemRIM 187 Million JPY -6006.952%
CellSource Co., Ltd. 677.73 Million JPY -1585.014%
FunPep Company Limited 189.32 Million JPY -5931.987%
Kringle Pharma, Inc. 596.95 Million JPY -1813.042%
Stella Pharma Corporation 1.44 Billion JPY -691.072%
TMS Co., Ltd. 97.68 Million JPY -11590.16%
Noile-Immune Biotech Inc. 91.49 Million JPY -12381.693%
Cuorips Inc. 200.96 Million JPY -5582.695%
K Pharma,Inc. 209.13 Million JPY -5360.614%
ReproCELL Incorporated 741.03 Million JPY -1441.094%
PhoenixBio Co., Ltd. 917.71 Million JPY -1144.398%
StemCell Institute Inc. 3.85 Billion JPY -196.588%
Japan Tissue Engineering Co., Ltd. 908.43 Million JPY -1157.113%
CellSeed Inc. 301.04 Million JPY -3693.428%